US 12,168,657 B2
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
Stéphane Dorich, Pointe-Claire (CA); and Amandine Chefson, Montreal (CA)
Assigned to Ventus Therapeutics U.S., Inc., Waltham, MA (US)
Filed by Ventus Therapeutics U.S., Inc., Waltham, MA (US)
Filed on Nov. 9, 2022, as Appl. No. 17/984,018.
Application 17/984,018 is a continuation of application No. 17/704,983, filed on Mar. 25, 2022, granted, now 11,618,751.
Prior Publication US 2023/0303559 A1, Sep. 28, 2023
Int. Cl. C07D 471/04 (2006.01); A61P 25/28 (2006.01)
CPC C07D 471/04 (2013.01) [A61P 25/28 (2018.01)] 9 Claims
 
1. A compound of formula:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt, stereoisomer, and/or isotopic derivative thereof.